Physician profile
Barry Seidman
NPI 1730142951
$6,587.38
in general payments reported to CMS, 2019-2025
25 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,379 · 2020: $891 · 2021: $1,283 · 2022: $1,142 · 2023: $743 · 2024: $920 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $766.64 | 2019-2025 | Airsupra, Breztri |
| Esperion Therapeutics, INC. | $761.05 | 2020-2024 | Nexlizet, Nexletol |
| Janssen Pharmaceuticals, INC | $555.79 | 2019-2023 | Xarelto |
| Atricure, INC. | $505.03 | 2022-2024 | |
| Abbott Laboratories | $504.49 | 2019-2022 | |
| Novo Nordisk INC | $429.27 | 2019-2025 | Ozempic |
| Amgen INC. | $343.10 | 2019-2021 | |
| Medtronic, INC. | $309.19 | 2022-2023 | Ligasure, Intellis Adaptivestim |
| Edwards Lifesciences Corporation | $250.80 | 2019-2021 | |
| Lilly USA, LLC | $233.15 | 2022-2024 | Mounjaro |
| Silk Road Medical, INC. | $186.86 | 2022 | |
| W. L. Gore & Associates, INC. | $186.35 | 2019 | |
| Boston Scientific Corporation | $151.60 | 2023 | Watchman Flx |
| Shockwave Medical, INC | $140.41 | 2022 | |
| Zimmer Biomet Holdings, INC. | $135.00 | 2024 | A&E Medical / Sternalock Xp Rigid Fixation System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $131.69 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $120.60 | 2020 | |
| Medtronic Vascular, INC. | $119.88 | 2020 | |
| Procept Biorobotics Corporation | $113.91 | 2023 | Aquabeam Robotic System |
| Allergan, INC. | $113.24 | 2019 | |
| Idorsia Pharmaceuticals US INC | $111.19 | 2023 | Quviviq |
| Ekos Corporation | $109.75 | 2019 | |
| Cardiovascular Systems INC. | $109.46 | 2020 | |
| Glaxosmithkline, LLC. | $102.09 | 2021 | |
| Abbvie INC. | $96.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Seidman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.